Enanta Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Enanta Pharmaceuticals's balance sheet done over the years? Its assets were worth $376,652,000 last year, which is less than in the previous period. 66% of Enanta Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $247,838,000, which means an increase by 1% compared compared to last year.
Debt to Assets
| 2015 | 246013000 | 9.85M | 4.01% |
|---|---|---|---|
| 2016 | 281277000 | 11.34M | 4.03% |
| 2017 | 326637000 | 24.96M | 7.64% |
| 2018 | 414227000 | 20.54M | 4.96% |
| 2019 | 489829000 | 27.33M | 5.58% |
| 2020 | 486132000 | 30.55M | 6.28% |
| 2021 | 438791000 | 39.36M | 8.97% |
| 2022 | 375410000 | 54.07M | 14.4% |
| 2023 | 462275000 | 245.54M | 53.12% |
| 2024 | 376652000 | 247.83M | 65.8% |
ENTA Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 37.23M | 85.38M | 43.99M | 57.20M | 87.13M | 51.23M | 63.90M | 65.67M | 16.57M | 21.72M |
Short term investments | 210.95M | 284.52M | 205.23M | 186.79M | 299.51M | 284.00M | 244.82M | 157.99M | 193.50M | 123.47M |
Net receivables | 6.64M | 39.61M | 49.03M | 60.83M | 23.49M | 51.31M | 67.20M | 10.61M | 12.84M | 15.72M |
Inventory | 0 | 0 | 0 | -37.25M | 0 | 0 | 0 | 0 | 0 | 1 |
Other current assets | 45.02M | 13.26M | 13.44M | 51.44M | 26.69M | 15.29M | 4.45M | 7.07M | 9.23M | 17.98M |
Total current assets | 299.85M | 422.79M | 311.71M | 319.02M | 436.83M | 401.84M | 380.38M | 237.81M | 232.15M | 170.64M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 73.34M | 34.71M | 29.74M | 10.65M | 15.61M | 10.92M | 8.37M | 8.04M | 8.00M | 5.88M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 29.28M | 108.41M | 32.63M | 65.01M | 16.38M | 70.03M | 32.11M | 64.23M |
Other non-current assets | 3.45M | 4.77M | 4.66M | 700K | 700K | 700K | 700K | 608K | 608K | 608K |
Total non-current assets | 76.8M | 39.48M | 63.69M | 119.77M | 49.29M | 87.98M | 33.83M | 88.81M | 49.12M | 75.37M |
Total assets | 376.65M | 462.27M | 375.41M | 438.79M | 486.13M | 489.82M | 414.22M | 326.63M | 281.27M | 246.01M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.29M | 0 | 1.19M |
Short term debt | 3.04M | 5.27M | 2.89M | 4.20M | 4.26M | 0 | 0 | 79K | 73K | 69K |
Total current liabilities | 57.53M | 62.78M | 29.82M | 36.17M | 24.15M | 22.60M | 16.02M | 20.98M | 7.88M | 6.70M |
| Non-current liabilities: | ||||||||||
Long term debt | 53.94M | 21.23M | 22.37M | 1.12M | 3.83M | 200K | 293K | 379K | 458K | 529K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 136.36M | 161.51M | 1.87M | 2.06M | 1.07M | 3.1M | 2.89M | 3.6M | 2.04M | 2.62M |
Total non-current liabilities | 190.30M | 182.75M | 24.24M | 3.19M | 6.39M | 4.72M | 4.52M | 3.97M | 3.45M | 3.15M |
Total liabilities | 247.83M | 245.54M | 54.07M | 39.36M | 30.55M | 27.33M | 20.54M | 24.96M | 11.34M | 9.85M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |